ABSTRACT
PURPOSE: Cardiogenic shock secondary to acute myocardial infarction (AMI-CS) is associated with substantial short- and long-term morbidity and mortality. However, there are limited data on mental health sequelae that survivors experience following discharge. METHODS: We conducted a retrospective, population-based cohort study in Ontario, Canada of critically ill adult (≥ 18 years) survivors of AMI-CS, admitted to hospital between April 1, 2009 and March 31, 2019. We compared these patients to AMI survivors without shock. We captured outcome data using linked health administrative databases. The primary outcome was a new mental health diagnosis (a composite of mood, anxiety, or related disorders; schizophrenia/psychotic disorders; and other mental health disorders) following hospital discharge. We secondarily evaluated incidence of deliberate self-harm and death by suicide. We compared patients using overlap propensity score-weighted, cause-specific proportional hazard models. RESULTS: We included 7812 consecutive survivors of AMI-CS, from 135 centers. Mean age was 68.4 (standard deviation (SD) 12.2) years, and 70.3% were male. Median follow-up time was 767 days (interquartile range (IQR) 225-1682). Incidence of new mental health diagnosis among AMI-CS survivors was 109.6 per 1,000 person-years (95% confidence interval (CI) 105.4-113.9), compared with 103.8 per 1000 person-years (95% CI 102.5-105.2) among AMI survivors without shock. After propensity score adjustment, there was no difference in the risk of new mental health diagnoses following discharge [hazard ratio (HR) 0.99 (95% CI 0.94-1.03)]. Factors associated with new mental health diagnoses following AMI-CS included female sex, pre-existing mental health diagnoses, and discharge to a long-term hospital or rehabilitation institute. CONCLUSION: Survivors of AMI-CS experience substantial mental health morbidity following discharge. Risk of new mental health diagnoses was comparable between survivors of AMI with and without shock. Future research on interventions to mitigate psychiatric sequelae after AMI-CS is warranted.
Subject(s)
Myocardial Infarction , Shock, Cardiogenic , Survivors , Humans , Male , Female , Myocardial Infarction/complications , Myocardial Infarction/psychology , Myocardial Infarction/epidemiology , Shock, Cardiogenic/psychology , Shock, Cardiogenic/etiology , Shock, Cardiogenic/epidemiology , Aged , Retrospective Studies , Middle Aged , Ontario/epidemiology , Survivors/psychology , Survivors/statistics & numerical data , Mental Disorders/epidemiology , Mental Disorders/etiology , Mental Disorders/complications , Cohort Studies , Aged, 80 and over , Incidence , Mental HealthABSTRACT
BACKGROUND: Extracorporeal life support has become accepted as a rescue therapy for cardiopulmonary shock, and there have been over 100,000 extracorporeal membrane oxygenation (ECMO) cases since 1987. Rapid growth has presented ethical challenges and concerns. Here, we discuss core principles of bioethics in an attempt to more thoroughly appreciate the ethical concerns and considerations raised by use of this technology. METHODS: An extensive literature review was performed on current papers on ECMO and ethics. In this paper, we utilized 3 case studies to highlight 4 major tenets of bioethics as they relate to use of ECMO: autonomy, beneficence, nonmaleficence, and justice. RESULTS: Case studies presented involved unique perspectives on utilization of ECMO and a careful balance of benefits and harms as they relate to autonomy, beneficence, nonmaleficence and justice. We present nuanced interpretations of autonomy (eg, physician autonomy) and justice (eg, various providers interpret and offer ECMO differently). An additional challenge includes contending with potentially prolonged clinical courses and/or complications that either result directly from cannulation for ECMO or indirectly from being subject to ensuing extreme conditions and prolongation of life that medical science has yet to fully understand. CONCLUSIONS: ECMO programs continue to grow in number and capacity. A deep appreciation of the bioethical dimensions of this technology and its application must be pursued, understood and applied to individual patient scenarios.
Subject(s)
Bioethics , Extracorporeal Membrane Oxygenation/ethics , Morals , Shock, Cardiogenic/therapy , Adult , Aged, 80 and over , Female , Humans , Male , Middle Aged , Shock, Cardiogenic/psychologyABSTRACT
BACKGROUND: Altered mental status is among the signs of hypoperfusion in cardiogenic shock, the most severe form of acute heart failure. The aim of this study was to investigate the prevalence of altered mental status, to identify factors associating with it, and to assess the prognostic significance of altered mental status in cardiogenic shock. METHODS: Mental status was assessed at presentation of shock in 215 adult cardiogenic shock patients in a multinational, prospective, observational study. Clinical picture, biochemical variables, and short-term mortality were compared between patients presenting with altered and normal mental status. RESULTS: Altered mental status was detected in 147 (68%) patients, whereas 68 (32%) patients had normal mental status. Patients with altered mental status were older (68 vs. 64 years, p=0.04) and more likely to have an acute coronary syndrome than those with normal mental status (85% vs. 74%, p=0.04). Altered mental status was associated with lower systolic blood pressure (76 vs. 80 mmHg, p=0.03) and lower arterial pH (7.27 vs. 7.35, p<0.001) as well as higher levels of blood lactate (3.4 vs. 2.3 mmol/l, p<0.001) and blood glucose (11.4 vs. 9.0 mmol/l, p=0.01). Low arterial pH (adjusted odds ratio 1.6 (1.1-2.2), p=0.02) was the only factor independently associated with altered mental status. Ninety-day mortality was significantly higher (51% vs. 22%, p<0.001) among patients with altered mental status. CONCLUSIONS: Altered mental status is a common clinical sign of systemic hypoperfusion in cardiogenic shock and is associated with poor outcome. It is also associated with several biochemical findings that reflect inadequate tissue perfusion, of which low arterial pH is independently associated with altered mental status.
Subject(s)
Heart Failure/complications , Mental Health , Shock, Cardiogenic/mortality , Aged , Female , Finland/epidemiology , Humans , Male , Middle Aged , Prognosis , Prospective Studies , Risk Factors , Shock, Cardiogenic/etiology , Shock, Cardiogenic/psychology , Survival Rate/trendsABSTRACT
The two main objectives of this single-center, retrospective study were to analyze the outcomes and to identify the independent predictors of 30 day and long-term mortality in case of cardiopulmonary resuscitation requiring extracorporeal life support (ECLS) in the elderly patients. From October 2004 to May 2014, 163 patients with a mean age of 75.5 years (range 70-91) required veno-arterial ECLS. The main indication was postcardiotomy cardiogenic shock (79.6%). Extracorporeal life support duration averaged 5.6 ± 4.3 days. Thirty-day mortality was 72% (n = 117) and follow-up survival rate was 14.1% with a median follow-up of 23.7 months (range 1.5-102.3). Lactatemia was identified as an independent risk factor of 30 day mortality. Previous stroke, lactatemia, bilirubinemia, and ECLS implantation under cardiac massage were identified as independent risk factors for long-term mortality. Extracorporeal life support after TAVI procedure and intra-aortic balloon pump support were identified as protective factors for both 30 day and long-term survival. The 23 patients, still alive at last follow up, have a good quality of life, doing well, and self-catering. Although mortality rate at 30 days is more than 70% in elderly patients requiring circulatory support with ECLS, survivors can pretend to an acceptable long-term survival with a good quality of life. Extracorporeal life support implantation in the elderly patients should remain scarce, but should still be considered as a therapeutic option in well-selected patients.
Subject(s)
Extracorporeal Membrane Oxygenation , Shock, Cardiogenic/therapy , Aged , Aged, 80 and over , Extracorporeal Membrane Oxygenation/adverse effects , Female , Humans , Intra-Aortic Balloon Pumping/adverse effects , Male , Quality of Life , Retrospective Studies , Shock, Cardiogenic/mortality , Shock, Cardiogenic/psychologyABSTRACT
BACKGROUND: Mechanical circulatory support is increasingly used in acute cardiogenic shock. OBJECTIVE: To assess treatment strategies for cardiogenic shock. METHODS: Data of 57 patients in acute intrinsic cardiogenic shock treated with ECMO were analyzed. Different subsequent strategies (weaning, VAD, transplantation) were followed.â RESULTS: Overall 1, 2, and 4-year survival was 36.8 ± 6.4%, 32.2 ± 6.4%, 29.8 ± 6.3%. Elevated lactate and hemorrhagic complications (all p in patients with right heart failure prior to ECMO implantation, BVAD therapy showed a trend (p=0.058) towards superior survival compared with LVAD therapy. Seven of the BVAD patients received successful transplantation, with a 1-year survival of 71%. Among survivors Short Form 36 reported significantly lower combined physical scores (p=0.004). CONCLUSIONS: Right heart assessment prior to ECMO implantation may be beneficial to provide tailored therapy if ECMO weaning fails. Survival after cardiogenic shock requiring ECMO seems to be associated with impaired long-term quality of life.
Subject(s)
Extracorporeal Membrane Oxygenation/methods , Heart Failure/complications , Quality of Life , Shock, Cardiogenic/etiology , Adult , Female , Heart Failure/mortality , Heart Failure/therapy , Humans , Male , Middle Aged , Shock, Cardiogenic/mortality , Shock, Cardiogenic/psychology , Survival Rate/trends , Switzerland/epidemiologyABSTRACT
PURPOSE OF REVIEW: Mechanical Circulatory Support (MCS) devices are 'life-sustaining devices' placed as a bridge to decision, either recovery, transplantation or a lifetime tether with the device. Cardiogenic shock may compromise patient autonomy, or the right for an individual patient to determine his own care. This review addresses an ethical dilemma in the context of complex clinical medical decision-making, during marked uncertainty for outcomes. RECENT FINDINGS: The language in an advanced directive is often imprecise and may not provide clear guidance, especially for emergent decisions related to MCS devices. Despite improving outcomes, application of MCS in critical illness is associated with excessive morbidity and quality of life-limiting adverse outcomes. Several cohort experiences now exist that define deactivation of Left Ventricular Assist Devices (LVADs) in futility as now deemed as morally and ethically appropriate. In contradistinction to euthanasia, deactivation of an LVAD does not introduce new intervention or an additional surgical injury, thereby allowing the patient to die from their original disorder. SUMMARY: Clinicians must maintain the principle of patient autonomy, ensure the viability of an appropriate informed consent process and facilitate surrogate judgment. An interdisciplinary team-based approach is required, and, in some cases, assisted by formal ethics consultations in vexing situations.
Subject(s)
Euthanasia, Passive , Heart-Assist Devices , Life Support Care , Shock, Cardiogenic , Aged , Assisted Circulation/ethics , Assisted Circulation/psychology , Euthanasia, Passive/ethics , Euthanasia, Passive/psychology , Heart-Assist Devices/ethics , Heart-Assist Devices/psychology , Humans , Life Support Care/ethics , Life Support Care/methods , Life Support Care/psychology , Male , Medical Futility , Personal Autonomy , Quality of Life , Resuscitation Orders , Shock, Cardiogenic/psychology , Shock, Cardiogenic/therapyABSTRACT
BACKGROUND: The severity of pre-implantation heart failure may affect post-implantation health-related quality of life (HRQOL). The purpose of our study was to examine differences in HRQOL from before mechanical circulatory support (MCS) through 1 year after surgery by Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) patient profiles. METHODS: Data from 1,559 adults with advanced heart failure who received primary continuous-flow pumps between June 23, 2006, and March 31, 2010, and were enrolled in INTERMACS were analyzed. HRQOL data were collected using the EQ-5D-3L survey before implantation and at 3, 6, and 12 months after implantation. Statistical analyses included chi-square and t-tests, using all available data for each time period. Paired t-tests and sensitivity analyses were also conducted. RESULTS: HRQOL was poor before MCS implantation among patients with INTERMACS profiles 1 to 7 and significantly improved after MCS implantation for all profiles. Stratified by INTERMACS profile, problems within each of the 5 dimensions of HRQOL (i.e., mobility, self-care, usual activities, pain, and anxiety/depression) generally decreased from before to after implantation. By 6 months after implantation, patients with all INTERMACS profiles reported similar frequencies of problems for all HRQOL dimensions. Paired t-tests and sensitivity analyses supported almost all of our findings. CONCLUSIONS: HRQOL is poor among advanced heart failure patients with INTERMACS profiles 1 to 7 before MCS implantation and improves to similar levels for patients who remained on MCS 1 year after surgery. Patients have problems in HRQOL dimensions before and after MCS; however, the frequency of reporting problems decreases for all dimensions within most profiles across time.
Subject(s)
Heart Failure/psychology , Heart Failure/therapy , Heart-Assist Devices/psychology , Postoperative Complications/psychology , Quality of Life/psychology , Shock, Cardiogenic/psychology , Shock, Cardiogenic/therapy , Adult , Aged , Cohort Studies , Disability Evaluation , Female , Follow-Up Studies , Heart Failure/mortality , Heart Failure/physiopathology , Humans , Male , Middle Aged , Postoperative Complications/physiopathology , Shock, Cardiogenic/mortality , Shock, Cardiogenic/physiopathology , Surveys and Questionnaires , Survival AnalysisABSTRACT
BACKGROUND: Thanks to significant technical improvements, VA-ECMO is increasingly used to reverse circulatory collapse refractory to standard treatments. METHODS: We studied patients who underwent VA-ECMO due to primary cardiogenic shock or cardiac arrest between January 2008 and June 2011 at our institution. Variables related to hospital survival were analyzed. Long-term survival and health-related quality of life were checked. RESULTS: VA-ECMO was instituted in 23 patients: 17 outpatients and 6 inpatients. Seven of the outpatients were admitted to hospital under ongoing CPR. In these pts, time to CPR was 7 min (6-8) and time to ECMO 93 min (74-107); after 20 hours (16-22), all these pts died. Among remaining 16 pts, 6 were bridged to heart transplant and 4 to heart recovery, 8 survived to hospital discharge and 7 were alive with high health-related quality of life after 46 months (36-54). Ongoing CPR, inotropic score and lactates at cannulation did not differ between survivors and non-survivors; duration of shock, SOFA score and serum creatinine at ECMO institution, and lactates and fluid balance after 36 hours were higher in non-survivors. Patients could be kept on spontaneous breathing for >30% of time while on VA-ECMO. CONCLUSION: Emergency VA-ECMO institution can reverse refractory acute cardiovascular collapse, provided it is carried out before significant organ dysfunction occurs. Light sedation and spontaneous breathing while on VA-ECMO can be well tolerated by patients, but related clinical benefits should be proved. Patients successfully bridged to heart recovery or transplant are candidates for long-term good quality of life.
Subject(s)
Extracorporeal Membrane Oxygenation , Hospital Mortality , Quality of Life , Shock/mortality , Shock/therapy , Survival , Survivors/psychology , Adult , Cardiopulmonary Resuscitation , Emergency Medical Services , Female , Heart Arrest/mortality , Heart Arrest/psychology , Heart Arrest/therapy , Humans , Male , Middle Aged , Shock/psychology , Shock, Cardiogenic/mortality , Shock, Cardiogenic/psychology , Shock, Cardiogenic/therapy , Treatment Outcome , Ventilator WeaningABSTRACT
INTRODUCTION: Stress cardiopathy, also called "Tako Tsubo" is a cardiac pathology linked to an acute coronary syndrome with electrocardiographic signs and an increase in the level of cardiac enzymes, without any abnormality on coronarography. This syndrome is secondary to great physical or mental stress. Mortality and the risk of recurrence are low. However, there is no consensus for treatment or prevention. CASE REPORT: We report the case of 75-year-old woman presenting recurrent cardiogenic shocks. A symptomatic sinusal dysfunction motivated the introduction of a pacemaker in March 2008. One month later, she was hospitalized for a new cardiogenic shock with left ventricular dysfunction, a 40% ejection fraction, and a third degree mitral insufficiency. Cardiac enzymes were initially elevated. Electrocardiogram showed an ST elevation. The transthoracic echocardiogram revealed a left anterolateral ventriculogram dysfunction, and cardiac catheterization showed healthy coronary arteries. The cardiologist wondered about the existence of an anxiodepressive syndrome. No personal psychiatric background was known. The patient was widowed 3 years earlier. She described herself as a naturally anxious person. She hadn't experienced any recent stressing event. She was not depressed and wasn't taking any psychotropic drug. Her family was caring for her. The next day, the patient had another cardiogenic shock and died a few hours later. Maybe the introduction of the pacemaker occasioned one more stress for this patient DISCUSSION: We know that people with a stressing job have probably more chance to suffer a myocardial infarction (the risks are 1.5 or two times greater for them). The prevalence of cardiomyopathy syndrome is 4.9% for women. These women have gone through the menopause, with a history of hypertension and anxiodepressive symptoms. However, we do not find any similar description (behavioural scheme type A) as is shown by the psychosomatic school in cases of patients who have gone through myocardial infarction. We also can question ourselves about the fact that some people can be predisposed to suffer from "Tako Tsubo" cardiomyopathy and about the existence of personality disorders. What then is the role of the psychiatrist with these patients?
Subject(s)
Acute Coronary Syndrome/psychology , Acute Coronary Syndrome/therapy , Psychiatry , Referral and Consultation , Takotsubo Cardiomyopathy/psychology , Takotsubo Cardiomyopathy/therapy , Acute Coronary Syndrome/diagnosis , Acute Coronary Syndrome/mortality , Aged , Cooperative Behavior , Coronary Angiography , Diagnosis, Differential , Echocardiography , Fatal Outcome , Female , Humans , Interdisciplinary Communication , Pacemaker, Artificial/psychology , Recurrence , Risk Factors , Shock, Cardiogenic/diagnosis , Shock, Cardiogenic/psychology , Shock, Cardiogenic/therapy , Stress, Psychological/complications , Takotsubo Cardiomyopathy/diagnosis , Takotsubo Cardiomyopathy/mortalityABSTRACT
OBJECTIVE: Myocarditis is a rare disease that may progress rapidly to refractory cardiogenic shock and death. In such situations, emergent initiation of mechanical circulatory assistance is the only therapeutic option to rescue these dying patients. This study was designed to evaluate the outcomes, health-related quality of life and frequencies of anxiety, depression and posttraumatic stress disorder symptoms in fulminant myocarditis patients rescued by mechanical circulatory assistance, since these major components of outcome evaluation after serious illnesses have not yet been assessed in this setting. DESIGN: A retrospective, single-center, observational study and a cross-sectional survey to assess health-related quality of life by the Short Form-36 questionnaire and frequencies of anxiety, depression and posttraumatic stress disorder symptoms by the Hospital Anxiety and Depression Scale and the Impact of Event Scale, respectively. SETTING: An 18-bed tertiary intensive care unit in a university hospital. PATIENTS: We analyzed the short- and long-term outcomes of 41 patients hospitalized at our institution between 2003 and 2009 and who received either a Thoratec BiVAD (Thoratec, Pleasanton, CA) (n = 6) or extracorporeal membrane oxygenation (n = 35) to combat refractory cardiogenic shock due to fulminant myocarditis. MEASUREMENTS AND MAIN RESULTS: Intensive care unit survival was 68%, and four (10%) patients underwent heart transplantation. Independent predictors of in-intensive care unit death were Simplified Acute Physiology Score II ≥56 (odds ratio = 10.23) and troponin Ic ≥12 µg/L (odds ratio = 7.49) at admission. Complete follow-up (median, 525 days) was available for 26 of 28 survivors. Compared to age- and sex-matched controls, Short Form-36 evaluation of health-related quality of life revealed satisfactory mental health and vitality but persistent physical and psychosocial-related difficulties. Lastly, anxiety, depression, and/or posttraumatic stress disorder symptoms were reported by 38%, 27% and 27% of the patients, respectively. CONCLUSIONS: Mechanical circulatory assistance rescued 68% of patients with refractory circulatory failure due to fulminant myocarditis. Greater disease severity and higher troponin Ic levels at extracorporeal membrane oxygenation initiation predicted poorer prognosis. Because up to one-third of the patients reported anxiety, depression, and/or posttraumatic stress disorder symptoms, strategies aimed at attenuating their emotional and psychologic distress might significantly improve their long-lasting well-being.
Subject(s)
Extracorporeal Membrane Oxygenation/mortality , Heart-Assist Devices/psychology , Myocarditis/complications , Quality of Life , Shock, Cardiogenic/therapy , Adult , Cohort Studies , Critical Care/methods , Critical Illness/mortality , Cross-Sectional Studies , Disease Progression , Extracorporeal Membrane Oxygenation/methods , Female , Follow-Up Studies , France , Humans , Intensive Care Units , Male , Middle Aged , Multivariate Analysis , Myocarditis/diagnosis , Myocarditis/psychology , Myocarditis/therapy , Predictive Value of Tests , Retrospective Studies , Risk Assessment , Shock, Cardiogenic/diagnosis , Shock, Cardiogenic/mortality , Shock, Cardiogenic/psychology , Surveys and Questionnaires , Survivors , Time Factors , Treatment Outcome , Young AdultSubject(s)
Extracorporeal Membrane Oxygenation/methods , Postoperative Care/methods , Shock, Cardiogenic/therapy , Cardiac Surgical Procedures/adverse effects , Follow-Up Studies , Hospital Mortality/trends , Humans , Quality of Life , Risk Factors , Shock, Cardiogenic/mortality , Shock, Cardiogenic/psychology , Time FactorsABSTRACT
BACKGROUND: We retrospectively evaluated the early and intermediate results of use of temporary extracorporeal membrane oxygenation (ECMO) support and examined its effect on quality of life (QOL). METHODS: Over four years 62 of 12,644 patients (0.49%) undergoing cardiac surgery (valve procedures, n = 39; coronary artery bypass grafting, n = 13; coronary artery bypass grafting plus valve procedures, n = 4; heart transplantation, n = 4; and total aortic arch replacement, n = 2) required temporary postoperative ECMO support. During a follow-up study (mean 2.3 +/- 1.5 years, 100% complete), 32 were still alive and answered the Short-Form 36 Health Survey QOL questionnaire. RESULTS: The mean duration of ECMO support was 61 +/- 37 hours. Forty patients (64.5%) were successfully weaned from ECMO. Thirty-four patients (54.8%) were discharged from the hospital after 44.3 +/- 17.6 days. The in-hospital mortality rate was 45.2% and the main cause of death was multiple organ failure. A risk factor for in-hospital death was a peak lactate level greater than 12 mol/L before ECMO initiation. There were few significant differences in the mean QOL scores between the ECMO survivors and other patients who had undergone cardiac surgery without ECMO support; only the measures of vitality and mental health were significantly lower in the ECMO survivors (p < 0.05). Both the ECMO survivors and the patients who did not receive ECMO support had significantly lower QOL scores (except for vitality and mental health) than the general Chinese population (p < 0.05). CONCLUSIONS: Extracorporeal membrane oxygenation is an acceptable technique for the treatment of postoperative cardiogenic shock in adults, although early intervention and reduced complications could improve results. However, the use of ECMO has little influence on QOL.
Subject(s)
Extracorporeal Membrane Oxygenation/methods , Postoperative Care/methods , Shock, Cardiogenic/therapy , Adult , Cardiac Surgical Procedures/adverse effects , Cause of Death/trends , China/epidemiology , Female , Follow-Up Studies , Hospital Mortality/trends , Humans , Male , Middle Aged , Postoperative Complications , Quality of Life , Retrospective Studies , Risk Factors , Shock, Cardiogenic/mortality , Shock, Cardiogenic/psychology , Surveys and Questionnaires , Time Factors , Treatment OutcomeABSTRACT
Tako-Tsubo cardiomyopathy (TTC) which is usually precipitated by profound emotional and physical stress has been widely reported in the past. In this case we report a young female patient who developed sudden dyspnea and palpitation after an profound stress (fierce argument).The patient had characteristic feature of progressive pulmonary edema. Her symptom worsened gradually leading to cardiopulmonary arrest in a few hours from the onset. After resuscitation an immediately performed echocardiography showed a severe mitral regurgitation due to rupture of antromedial papillary muscle. Left ventricular function showed akinetic mid-to-distal portion of the left ventricular chamber and hyperkinetic in basal segment. Inotrop infusion and aortic balloon pump placement was done because of unstable homodynamics. Semi-elective surgical valve replacement was performed. One year after the acute event the patient remained asymptomatic. Clinicians should recognize that Tako-Tsubo cardiomyopathy is one etiology of acute pulmonary edema with normal coronary artery finding.
Subject(s)
Heart Arrest/diagnosis , Mitral Valve Insufficiency/diagnosis , Shock, Cardiogenic/diagnosis , Stress, Psychological/diagnosis , Takotsubo Cardiomyopathy/diagnosis , Adult , Female , Heart Arrest/etiology , Heart Arrest/psychology , Humans , Mitral Valve Insufficiency/etiology , Mitral Valve Insufficiency/psychology , Shock, Cardiogenic/etiology , Shock, Cardiogenic/psychology , Stress, Psychological/complications , Stress, Psychological/psychology , Takotsubo Cardiomyopathy/etiology , Takotsubo Cardiomyopathy/psychologyABSTRACT
Emotional stress is a recognized trigger for coronary artery spasm. An association between dreams and sudden death is described in folklore and medical history, and originates from the common experience of being awakened by vivid, frightening dreams, with racing pulse, cold sweats and other physiological responses associated with intense distress. Intense alterations in autonomic activity during dreaming can have dire consequences in patients with cardiovascular disease. Four patients with no evidence of underlying coronary artery disease, where emotional stress produced by nightmares or 'deadly dreams' caused coronary artery dissection in two and vasospasm in the other two, leading to life-threatening cardiac events, are presented. A possible mechanism is speculated.
Subject(s)
Dreams , Adult , Coronary Vasospasm/diagnosis , Coronary Vasospasm/etiology , Coronary Vasospasm/physiopathology , Coronary Vasospasm/psychology , Dreams/physiology , Dreams/psychology , Fatal Outcome , Female , Humans , Male , Middle Aged , Myocardial Infarction/diagnosis , Myocardial Infarction/etiology , Myocardial Infarction/physiopathology , Myocardial Infarction/psychology , Psychophysiology , Shock, Cardiogenic/diagnosis , Shock, Cardiogenic/etiology , Shock, Cardiogenic/physiopathology , Shock, Cardiogenic/psychology , Stress, Psychological/complications , Stress, Psychological/diagnosis , Stress, Psychological/physiopathology , Stress, Psychological/psychologyABSTRACT
1. Cardiogenic shock is a state of acute circulatory failure precipitated by extensive left ventricular damage. 2. Nursing care of patients with cardiogenic shock must treat the 'whole person', and incorporate such elements as maintaining a safe environment; effective communication; nutrition and mobility. 3. Cardiogenic shock has a high mortality rate and is, therefore, very distressing for patients. Nursing care must ensure all patients are treated with respect and dignity.